| Paxxon Healthcare Services Llc | |
|
1035 Madison St, Oak Park, IL 60302-4449 | |
| (708) 848-7200 | |
| Not Available |
| Full Name | Paxxon Healthcare Services Llc |
|---|---|
| Type | Facility |
| Speciality | Physical Therapist |
| Location | 1035 Madison St, Oak Park, Illinois |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063784148 | NPI | - | NPPES |
| Provider Name | Edward J Karius |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1558422543 PECOS PAC ID: 7416943105 Enrollment ID: I20040423000378 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Itiona M Scott |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1760580963 PECOS PAC ID: 8426053612 Enrollment ID: I20060921000369 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Madhulika Char |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1558467910 PECOS PAC ID: 3375542525 Enrollment ID: I20061215000347 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | James A Dallas |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1265465116 PECOS PAC ID: 9335045756 Enrollment ID: I20070202000256 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Rochell Villamar |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1932272622 PECOS PAC ID: 3274636857 Enrollment ID: I20070320000443 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Alwayne S Tulayba |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1558485342 PECOS PAC ID: 7315032232 Enrollment ID: I20071005000727 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Faten Shaabneh |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1902970643 PECOS PAC ID: 0547328908 Enrollment ID: I20081029000393 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Marcus G Matthews |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1962725515 PECOS PAC ID: 0648301671 Enrollment ID: I20100708000182 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Mary O Sodimu |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1871792986 PECOS PAC ID: 6608032917 Enrollment ID: I20120731000406 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Lisa M Cardella |
|---|---|
| Provider Type | Practitioner - Qualified Speech Language Pathologist |
| Provider Identifiers | NPI Number: 1942564828 PECOS PAC ID: 2668638974 Enrollment ID: I20120731000436 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Erin E Cannella |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1881942373 PECOS PAC ID: 2860644259 Enrollment ID: I20121211000398 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Elizabeth M Spink |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1609893346 PECOS PAC ID: 6204080500 Enrollment ID: I20130215000034 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Sheryl B Bucasas |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1629327838 PECOS PAC ID: 0446495386 Enrollment ID: I20130326000381 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Judith Chavira |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1013257559 PECOS PAC ID: 6709023161 Enrollment ID: I20130503000097 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Harpreet K Kang |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1780029314 PECOS PAC ID: 5799927927 Enrollment ID: I20130816000636 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Sarah Jane U Castro |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1790068518 PECOS PAC ID: 7810129111 Enrollment ID: I20140421002139 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Elizabeth A Sledge |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1972917557 PECOS PAC ID: 5890911267 Enrollment ID: I20140721000287 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Ria C Malonzo |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1619383908 PECOS PAC ID: 5092931733 Enrollment ID: I20140801000434 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Bernadette Cadiz Jackson |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1821328733 PECOS PAC ID: 7113146804 Enrollment ID: I20140911000328 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Krista N Wynkoop |
|---|---|
| Provider Type | Practitioner - Qualified Speech Language Pathologist |
| Provider Identifiers | NPI Number: 1487051942 PECOS PAC ID: 4981927910 Enrollment ID: I20141226000547 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Kimberly M Libby |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1841690898 PECOS PAC ID: 6305160755 Enrollment ID: I20150113002374 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Conrado Peralta |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1952656753 PECOS PAC ID: 5395062244 Enrollment ID: I20150402001175 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Megan K Thomas |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1275967572 PECOS PAC ID: 1153638531 Enrollment ID: I20150917000542 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Lukas J Starck |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1043689706 PECOS PAC ID: 5890004634 Enrollment ID: I20151019002013 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Maria Theresa M Carabeo |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1518148667 PECOS PAC ID: 3870899180 Enrollment ID: I20160314000749 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Jessica L Nebrija |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1770771156 PECOS PAC ID: 1951693225 Enrollment ID: I20160706001932 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Kristin M Saluja |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1679922181 PECOS PAC ID: 0749572402 Enrollment ID: I20160718000264 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Joyce L Hart |
|---|---|
| Provider Type | Practitioner - Qualified Speech Language Pathologist |
| Provider Identifiers | NPI Number: 1215307475 PECOS PAC ID: 9133415060 Enrollment ID: I20160901001236 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Carey M Payne |
|---|---|
| Provider Type | Practitioner - Qualified Speech Language Pathologist |
| Provider Identifiers | NPI Number: 1881837920 PECOS PAC ID: 0941589626 Enrollment ID: I20161121001526 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Gisselle P Guingon |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1265709224 PECOS PAC ID: 0941582183 Enrollment ID: I20170123001952 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Abigail A Ocon |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1972045292 PECOS PAC ID: 1557644309 Enrollment ID: I20170202000171 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Gemmy H Ambatt |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1306386909 PECOS PAC ID: 4082998265 Enrollment ID: I20170307002603 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Natalie P Neps |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1851824411 PECOS PAC ID: 1052697646 Enrollment ID: I20170414000000 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Sandra E Schultz |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1871905240 PECOS PAC ID: 5991064586 Enrollment ID: I20180104000420 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Sonal V Patel |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1982955423 PECOS PAC ID: 8527322197 Enrollment ID: I20180507001793 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Aimee A Tabilon |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1942558937 PECOS PAC ID: 7719233899 Enrollment ID: I20180703000123 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Amelia R Calapatia-poirot |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1609264753 PECOS PAC ID: 6103176748 Enrollment ID: I20180901000094 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Binky Bawa |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1770972473 PECOS PAC ID: 7517222383 Enrollment ID: I20190313000663 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Diane K Bittman |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1649402579 PECOS PAC ID: 6406995018 Enrollment ID: I20190417001363 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Nicole Valle |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1326507468 PECOS PAC ID: 0648512970 Enrollment ID: I20190507000028 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Melissa Olsen |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1902203433 PECOS PAC ID: 0840533881 Enrollment ID: I20190515001505 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Alana N Hansen |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1700344140 PECOS PAC ID: 1850625203 Enrollment ID: I20190619000827 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Kristen Schwartz |
|---|---|
| Provider Type | Practitioner - Qualified Speech Language Pathologist |
| Provider Identifiers | NPI Number: 1417515818 PECOS PAC ID: 9436483393 Enrollment ID: I20190626001665 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Eric S Forst |
|---|---|
| Provider Type | Practitioner - Qualified Speech Language Pathologist |
| Provider Identifiers | NPI Number: 1073172995 PECOS PAC ID: 9335473214 Enrollment ID: I20190626002585 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Magda L. Bowen |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1467964551 PECOS PAC ID: 3971838681 Enrollment ID: I20190717000638 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Robert Strauch |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1912475385 PECOS PAC ID: 0143556308 Enrollment ID: I20190725000860 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Lizli Anne Y Tomada |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1821640509 PECOS PAC ID: 7012245764 Enrollment ID: I20190820001788 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Danilyn Nguyen |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1740400464 PECOS PAC ID: 5193054658 Enrollment ID: I20190909001586 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Amy Susan Brandon |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1639300569 PECOS PAC ID: 5698004638 Enrollment ID: I20190917001049 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Hannah Gin |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1316593023 PECOS PAC ID: 0749510667 Enrollment ID: I20190919000743 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Morgan J Dolan |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1326696022 PECOS PAC ID: 6800128729 Enrollment ID: I20191025002574 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Rhia A Ducena |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1265605067 PECOS PAC ID: 5294167474 Enrollment ID: I20191108000343 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Hetal D Dutia |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1205044690 PECOS PAC ID: 5799117834 Enrollment ID: I20191112001434 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Annette M Zajac |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1831734763 PECOS PAC ID: 1052745460 Enrollment ID: I20191218000065 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Trevissa V Martis |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1457703282 PECOS PAC ID: 9931534849 Enrollment ID: I20200123001740 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Beth A Markese |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1790921427 PECOS PAC ID: 9537596622 Enrollment ID: I20200302002597 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Anna B Deeney |
|---|---|
| Provider Type | Practitioner - Qualified Speech Language Pathologist |
| Provider Identifiers | NPI Number: 1639719289 PECOS PAC ID: 2961830765 Enrollment ID: I20200310000106 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Lorelei Y Mariano |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1497394720 PECOS PAC ID: 4688004278 Enrollment ID: I20200422002643 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Noelle A Lauschke |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1871127530 PECOS PAC ID: 4082045018 Enrollment ID: I20200507001476 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Christine S Cooke |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1366062929 PECOS PAC ID: 7810318961 Enrollment ID: I20200528002048 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Hannah S Stone |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1952921777 PECOS PAC ID: 3779904198 Enrollment ID: I20200610001727 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Melissa M Dzugan |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1295358091 PECOS PAC ID: 8820410699 Enrollment ID: I20200624001097 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Samantha Cool Quick |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1790301000 PECOS PAC ID: 6709209901 Enrollment ID: I20200707001067 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Mansoor Kamal Sikander |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1710004627 PECOS PAC ID: 3072923168 Enrollment ID: I20201030000959 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Raymund Espiritu |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1154928141 PECOS PAC ID: 8224448618 Enrollment ID: I20201115000006 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Callie M Nolan |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1649883281 PECOS PAC ID: 6204247612 Enrollment ID: I20201116001282 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Cara L Warning |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1982202164 PECOS PAC ID: 7416360730 Enrollment ID: I20210106000748 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Brian R Creeron |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1356946826 PECOS PAC ID: 5395159008 Enrollment ID: I20210120002263 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Jessica Nitch |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1902495633 PECOS PAC ID: 4082029004 Enrollment ID: I20210224001103 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Leadene L Loconte |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1548704489 PECOS PAC ID: 0143636282 Enrollment ID: I20210315002329 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Jaycee Cabalatungan Cristales |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1073072609 PECOS PAC ID: 2264849330 Enrollment ID: I20210408000508 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Katelyn E Bormida |
|---|---|
| Provider Type | Practitioner - Qualified Speech Language Pathologist |
| Provider Identifiers | NPI Number: 1407387079 PECOS PAC ID: 8820406952 Enrollment ID: I20210409000471 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Mariene O Italia |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1154632099 PECOS PAC ID: 9638588510 Enrollment ID: I20210505000910 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Natalie M Fetzko |
|---|---|
| Provider Type | Practitioner - Qualified Speech Language Pathologist |
| Provider Identifiers | NPI Number: 1386226850 PECOS PAC ID: 9436558723 Enrollment ID: I20210518001594 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Nicole M Fuhs |
|---|---|
| Provider Type | Practitioner - Qualified Speech Language Pathologist |
| Provider Identifiers | NPI Number: 1407237571 PECOS PAC ID: 1951700244 Enrollment ID: I20210518001754 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Heather L Fisher |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1780858712 PECOS PAC ID: 0749689016 Enrollment ID: I20210519001637 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Erin K Dini |
|---|---|
| Provider Type | Practitioner - Qualified Speech Language Pathologist |
| Provider Identifiers | NPI Number: 1033775259 PECOS PAC ID: 2062812480 Enrollment ID: I20210607001616 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Kim M. Cecchi |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1851670715 PECOS PAC ID: 3072785997 Enrollment ID: I20210609002070 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Sakina A Morbiwala |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1144781147 PECOS PAC ID: 1951702190 Enrollment ID: I20210625001453 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Nikko D Gonzales |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1588239784 PECOS PAC ID: 5698177632 Enrollment ID: I20210713001962 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Jessica A Paulose |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1902911712 PECOS PAC ID: 4688603608 Enrollment ID: I20210715003491 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Liz S Maliakal |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1053822619 PECOS PAC ID: 1557764768 Enrollment ID: I20210726003232 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Hem Dave |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1558308585 PECOS PAC ID: 2466455894 Enrollment ID: I20210728003630 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Nina N Yu |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1962175869 PECOS PAC ID: 1355746405 Enrollment ID: I20210827000258 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Snehaben Kishankumar Patel |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1568136414 PECOS PAC ID: 9638575525 Enrollment ID: I20210831003530 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Tyler A Davila |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1265105738 PECOS PAC ID: 0749686616 Enrollment ID: I20210901002975 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Laura P Otto |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1922772185 PECOS PAC ID: 2062818123 Enrollment ID: I20210915001457 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Emily Miron |
|---|---|
| Provider Type | Practitioner - Qualified Speech Language Pathologist |
| Provider Identifiers | NPI Number: 1548933799 PECOS PAC ID: 6204233737 Enrollment ID: I20210924002381 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Alexandra Harrer |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1205502150 PECOS PAC ID: 0648677179 Enrollment ID: I20210924002462 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Patrick M Maddigan |
|---|---|
| Provider Type | Practitioner - Qualified Speech Language Pathologist |
| Provider Identifiers | NPI Number: 1306418066 PECOS PAC ID: 2466859905 Enrollment ID: I20210924002963 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Ketki Ajit Raktavan |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1992303820 PECOS PAC ID: 2668892944 Enrollment ID: I20210927000126 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Sonal Bhandari |
|---|---|
| Provider Type | Practitioner - Qualified Speech Language Pathologist |
| Provider Identifiers | NPI Number: 1629382759 PECOS PAC ID: 0648677161 Enrollment ID: I20210927002366 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Eva Szulc |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1154099547 PECOS PAC ID: 6204233455 Enrollment ID: I20210930001556 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Jenna N Abi-mansour |
|---|---|
| Provider Type | Practitioner - Qualified Speech Language Pathologist |
| Provider Identifiers | NPI Number: 1659049450 PECOS PAC ID: 7517365356 Enrollment ID: I20211008002482 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Maria L Gribb |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1720740699 PECOS PAC ID: 8123416518 Enrollment ID: I20211104001790 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Jorek Bordas Combenido |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1124527650 PECOS PAC ID: 6204225014 Enrollment ID: I20211117001550 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Mia Angelica P Combenido |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1710487608 PECOS PAC ID: 3577952068 Enrollment ID: I20211123001722 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Jodi L Boe |
|---|---|
| Provider Type | Practitioner - Qualified Speech Language Pathologist |
| Provider Identifiers | NPI Number: 1164186094 PECOS PAC ID: 8729479332 Enrollment ID: I20211215000829 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Krupali P Patel |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1689332520 PECOS PAC ID: 5890186704 Enrollment ID: I20220104001902 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Jordan B Juralbal |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1518626274 PECOS PAC ID: 9638560337 Enrollment ID: I20220106000444 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Ethel S Juralbal |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1417226432 PECOS PAC ID: 2961893672 Enrollment ID: I20220106000608 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Elizabeth Levine |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1275910028 PECOS PAC ID: 6204227929 Enrollment ID: I20220106001260 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Sarah M Thomas |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1831708106 PECOS PAC ID: 0941610489 Enrollment ID: I20220131001339 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Shweta V Patel |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1568035798 PECOS PAC ID: 0648663252 Enrollment ID: I20220203000271 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Jessica Pasowicz |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1275291338 PECOS PAC ID: 4385037886 Enrollment ID: I20220204001363 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Shannon Fogarty |
|---|---|
| Provider Type | Practitioner - Qualified Speech Language Pathologist |
| Provider Identifiers | NPI Number: 1225789050 PECOS PAC ID: 8426441932 Enrollment ID: I20220204002051 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Shamun N Mohammed |
|---|---|
| Provider Type | Practitioner - Qualified Speech Language Pathologist |
| Provider Identifiers | NPI Number: 1083120539 PECOS PAC ID: 3678966645 Enrollment ID: I20220215002512 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Kimberly L Hicks |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1184378259 PECOS PAC ID: 5597150581 Enrollment ID: I20220309001016 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Patrick J Montag |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1467108951 PECOS PAC ID: 4385039866 Enrollment ID: I20220318002336 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Yolanda White |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1033431119 PECOS PAC ID: 5991197055 Enrollment ID: I20220324000067 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Mariene O Italia |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1154632099 PECOS PAC ID: 9638588510 Enrollment ID: I20220415000801 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Alexa F Hollenbeck |
|---|---|
| Provider Type | Practitioner - Qualified Speech Language Pathologist |
| Provider Identifiers | NPI Number: 1295483584 PECOS PAC ID: 4284021221 Enrollment ID: I20220421002575 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Elsy Motr/l Michael |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1629496997 PECOS PAC ID: 4183011497 Enrollment ID: I20220504002169 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Amrit K Gill |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1720397276 PECOS PAC ID: 7618159211 Enrollment ID: I20220505002297 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Mindy A Kaplan |
|---|---|
| Provider Type | Practitioner - Qualified Speech Language Pathologist |
| Provider Identifiers | NPI Number: 1245505718 PECOS PAC ID: 9537546973 Enrollment ID: I20220524002022 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Donald Algozine |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1578206397 PECOS PAC ID: 4183001530 Enrollment ID: I20220524002488 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Kerby L Obia |
|---|---|
| Provider Type | Practitioner - Qualified Speech Language Pathologist |
| Provider Identifiers | NPI Number: 1255987293 PECOS PAC ID: 7012395924 Enrollment ID: I20220606001883 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Joshua M Reyes |
|---|---|
| Provider Type | Practitioner - Qualified Speech Language Pathologist |
| Provider Identifiers | NPI Number: 1134507676 PECOS PAC ID: 5597144709 Enrollment ID: I20220617002462 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Cara Love P De Asis |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1659028686 PECOS PAC ID: 2961885470 Enrollment ID: I20220816003618 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Maria L Mendoza |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1962811828 PECOS PAC ID: 2860875291 Enrollment ID: I20220818000857 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Erica L Toth |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1538732672 PECOS PAC ID: 2466835897 Enrollment ID: I20220818001011 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Sarah A Kruse |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1437883139 PECOS PAC ID: 5698158905 Enrollment ID: I20220819000750 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Hannah K Moll |
|---|---|
| Provider Type | Practitioner - Qualified Speech Language Pathologist |
| Provider Identifiers | NPI Number: 1013582824 PECOS PAC ID: 4587047766 Enrollment ID: I20220822000595 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Laura A Flahaven |
|---|---|
| Provider Type | Practitioner - Qualified Speech Language Pathologist |
| Provider Identifiers | NPI Number: 1396083572 PECOS PAC ID: 5698158871 Enrollment ID: I20220822000953 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Matthew D Lau |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1003546003 PECOS PAC ID: 2365825551 Enrollment ID: I20220822001212 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Zeba Khan |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1881327070 PECOS PAC ID: 9335522390 Enrollment ID: I20220824001416 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Rebecca M Fraedrich |
|---|---|
| Provider Type | Practitioner - Qualified Speech Language Pathologist |
| Provider Identifiers | NPI Number: 1699390559 PECOS PAC ID: 7012391147 Enrollment ID: I20220908001447 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Christopher T Miles |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1629732193 PECOS PAC ID: 0143604280 Enrollment ID: I20220908002201 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Jennifer A Weigand |
|---|---|
| Provider Type | Practitioner - Qualified Speech Language Pathologist |
| Provider Identifiers | NPI Number: 1376802330 PECOS PAC ID: 7113303314 Enrollment ID: I20220926000931 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Isha B Patel |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1770201170 PECOS PAC ID: 0143606418 Enrollment ID: I20221011000323 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Todd J Riefenberg |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1093436305 PECOS PAC ID: 7517333867 Enrollment ID: I20221012001215 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Andrea E Ortiz |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1205563871 PECOS PAC ID: 4981070935 Enrollment ID: I20221017002920 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Taylor D Coblentz |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1417678996 PECOS PAC ID: 7012383433 Enrollment ID: I20221026000682 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Christine Bacharo Villamor |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1023283512 PECOS PAC ID: 9436526878 Enrollment ID: I20221027002773 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Emma E Lagger |
|---|---|
| Provider Type | Practitioner - Qualified Speech Language Pathologist |
| Provider Identifiers | NPI Number: 1083335202 PECOS PAC ID: 3476920125 Enrollment ID: I20221109001005 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Jaelin M Mankins |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1871218586 PECOS PAC ID: 4880062702 Enrollment ID: I20221128001920 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Jennifer M Pfeiffer |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1710603238 PECOS PAC ID: 9335517044 Enrollment ID: I20221129003317 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Mia Anica K Fuentebella |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1710558465 PECOS PAC ID: 0244609949 Enrollment ID: I20221219001598 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Stacy Grossman |
|---|---|
| Provider Type | Practitioner - Qualified Speech Language Pathologist |
| Provider Identifiers | NPI Number: 1366829046 PECOS PAC ID: 0547630451 Enrollment ID: I20230110000675 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Danielle M Havlik |
|---|---|
| Provider Type | Practitioner - Qualified Speech Language Pathologist |
| Provider Identifiers | NPI Number: 1720716582 PECOS PAC ID: 2769853993 Enrollment ID: I20230125002012 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Margaret R Hindmand |
|---|---|
| Provider Type | Practitioner - Qualified Speech Language Pathologist |
| Provider Identifiers | NPI Number: 1730809435 PECOS PAC ID: 3375914526 Enrollment ID: I20230125002790 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Fernando Hurtado |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1538650957 PECOS PAC ID: 2961874441 Enrollment ID: I20230209001261 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Michelle V Neri |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1245413558 PECOS PAC ID: 8527431303 Enrollment ID: I20230224002113 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Madison M Virden |
|---|---|
| Provider Type | Practitioner - Qualified Speech Language Pathologist |
| Provider Identifiers | NPI Number: 1942924246 PECOS PAC ID: 5395119721 Enrollment ID: I20230324002334 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Janet L Brancato |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1356047005 PECOS PAC ID: 2163896507 Enrollment ID: I20230324002620 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Raquel Z May |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1861192494 PECOS PAC ID: 2860867983 Enrollment ID: I20230403002365 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Davache N Taylor |
|---|---|
| Provider Type | Practitioner - Qualified Speech Language Pathologist |
| Provider Identifiers | NPI Number: 1902306319 PECOS PAC ID: 7214392232 Enrollment ID: I20230426002867 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Tina M Wilkens |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1255505210 PECOS PAC ID: 7517322027 Enrollment ID: I20230504001872 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Jessica J Zduniewicz |
|---|---|
| Provider Type | Practitioner - Qualified Speech Language Pathologist |
| Provider Identifiers | NPI Number: 1902592140 PECOS PAC ID: 5698131654 Enrollment ID: I20230518002172 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Dulari Patel |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1558051284 PECOS PAC ID: 1153787031 Enrollment ID: I20230518002592 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Khushkaran S Brar |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1720762602 PECOS PAC ID: 1456719368 Enrollment ID: I20230626002111 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Carlo Cordero |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1407211501 PECOS PAC ID: 1153780911 Enrollment ID: I20230711003657 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Lindsey N Skinner |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1639860075 PECOS PAC ID: 3173983293 Enrollment ID: I20230720000700 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Dhanya Thomas |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1356057848 PECOS PAC ID: 9032570767 Enrollment ID: I20230727003588 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Khyati Malhotra |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1336465491 PECOS PAC ID: 8527429042 Enrollment ID: I20230801001146 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Ashley Y Pak |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1528707999 PECOS PAC ID: 8224499546 Enrollment ID: I20230803000752 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Trina E Patel |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1639663974 PECOS PAC ID: 4284095415 Enrollment ID: I20230803001920 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Meetal Dave |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1750065090 PECOS PAC ID: 1557723434 Enrollment ID: I20230809000948 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Rebecca A Lapp |
|---|---|
| Provider Type | Practitioner - Qualified Speech Language Pathologist |
| Provider Identifiers | NPI Number: 1700436011 PECOS PAC ID: 5991167603 Enrollment ID: I20230811003020 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Iris M Espinoza |
|---|---|
| Provider Type | Practitioner - Qualified Speech Language Pathologist |
| Provider Identifiers | NPI Number: 1629767298 PECOS PAC ID: 5991168346 Enrollment ID: I20230831003982 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Kelsie J Moosmann |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1225716285 PECOS PAC ID: 1658734033 Enrollment ID: I20230901000425 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Mianie J Macias |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1407471634 PECOS PAC ID: 3476916719 Enrollment ID: I20230901003472 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Alison Elizabeth Kennedy |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1245494202 PECOS PAC ID: 7719018431 Enrollment ID: I20230912001288 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Heather L Gonzalez |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1538942289 PECOS PAC ID: 4183079221 Enrollment ID: I20231010003545 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Taylor M Stazzone |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1922886084 PECOS PAC ID: 7517313299 Enrollment ID: I20231101001895 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Emily H Dyson |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1255110680 PECOS PAC ID: 1759739618 Enrollment ID: I20231204000081 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Fritzie D De Leon |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1073769097 PECOS PAC ID: 0749638609 Enrollment ID: I20231204000120 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Susan L Scherer Whalen |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1710153689 PECOS PAC ID: 8527417351 Enrollment ID: I20231205003706 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Haydee Y Castelo |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1598532806 PECOS PAC ID: 9133571458 Enrollment ID: I20240122004277 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Katie J Arnold |
|---|---|
| Provider Type | Practitioner - Qualified Speech Language Pathologist |
| Provider Identifiers | NPI Number: 1316717267 PECOS PAC ID: 4981048592 Enrollment ID: I20240221003606 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Sophia A Zaras |
|---|---|
| Provider Type | Practitioner - Qualified Speech Language Pathologist |
| Provider Identifiers | NPI Number: 1194455287 PECOS PAC ID: 2466897459 Enrollment ID: I20240229001919 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Provider Name | Phaedra M Luna |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1043615487 PECOS PAC ID: 6709101215 Enrollment ID: I20240304000796 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Paxxon Healthcare Services Llc 2222 Sullivan Trl, Easton, PA 18040-7958 Ph: (610) 438-2020 | Paxxon Healthcare Services Llc 1035 Madison St, Oak Park, IL 60302-4449 Ph: (708) 848-7200 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
Research undertaken at the University of Adelaide overturns the belief that turning your crooked teeth into a beautiful smile will automatically boost your self-confidence.
The GAVI Alliance pledging conference is "being seen as a litmus test of how well aid can survive in the age of austerity," columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as "soft power … to establish influence and spread values - which is often more useful than diplomacy or defence in a post-cold war world."
› Verified 4 days ago
Sarah Goldenberg, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 3 Erie Ct, Oak Park, IL 60302 Phone: 847-975-7675 | |
Bee Loved Kids Therapy, Inc. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1020 S East Ave, Oak Park, IL 60304 Phone: 630-240-1817 | |
Elizabeth M Smith, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 610 S Maple Ave Ste 1400, Oak Park, IL 60304 Phone: 708-383-0770 | |
Riley Guillet, PT, DPT Physical Therapist Medicare: May Accept Medicare Assignments Practice Location: 207 Harrison St, Oak Park, IL 60304 Phone: 312-391-8752 | |
Gina Kolk, P.T. Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 605 Madison St, Oak Park, IL 60302 Phone: 708-763-8597 Fax: 708-763-0978 | |
Christopher Michael Schmalz, PT, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 1049 Lake St Ste 201, Oak Park, IL 60301 Phone: 708-607-6040 |